Product Information

XERESE 5%-1% CREAM is a brand product labeled by Bausch Health US LLC, priced at $258.7892 per GM under NDC 00187510401. Its NADAC has been published 206 times since Nov 28, 2013.

XERESE 5%-1% CREAM

Acyclovir and Hydrocortisone
$258.7892per GM

Strength

50; 10 mg/g; mg/g

NDC

00187510401

Classification

Brand

Dosage Form

CREAM

Route

TOPICAL

Last Updated

9/17/2025

Active Ingredients

ACYCLOVIR; HYDROCORTISONE

Approval Type

New Drug (NDA)

FDA Application

NDA022436

On Market Since

7/31/2009

Price Statistics

The NADAC for XERESE 5%-1% CREAM has been published 206 times since Nov 28, 2013, and over the history we have for it it has risen 312.7%. The table below summarizes its recorded NADAC range and movement.

Current price$258.7892 per GM
All-time high$258.7892 (Oct 1, 2025)
All-time low$62.7062 (Nov 28, 2013)
52-week high$258.7892
52-week low$235.4770
Median price$199.5752
Average price$175.9914
Largest weekly change+30.0% (Jun 11, 2014)
Weeks tracked206
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+9.8%

3Y

+29.7%

5Y

+29.7%

All

+312.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Acyclovir and Hydrocortisone market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of XERESE 5%-1% CREAM?

The current National Average Drug Acquisition Cost (NADAC) for XERESE 5%-1% CREAM, manufactured by Bausch Health US LLC, is $258.7892 per GM (NDC 00187510401), effective Oct 1, 2025.

How has the price of XERESE 5%-1% CREAM changed over time?

Over the history we have for it, the NADAC for XERESE 5%-1% CREAM has risen 312.7%. It has been tracked across 206 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for XERESE 5%-1% CREAM?

Since Nov 28, 2013, the NADAC for XERESE 5%-1% CREAM has ranged from a low of $62.7062 (Nov 28, 2013) to a high of $258.7892 (Oct 1, 2025), with a median of $199.5752 per GM.

Are there cheaper alternatives to XERESE 5%-1% CREAM?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of XERESE 5%-1% CREAM, so no direct lower-cost alternative is listed.

Who manufactures XERESE 5%-1% CREAM?

XERESE 5%-1% CREAM (NDC 00187510401) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.